Literature DB >> 11705896

Human macrophage gamma interferon decreases gene expression but not replication of Mycobacterium tuberculosis: analysis of the host-pathogen reciprocal influence on transcription in a comparison of strains H37Rv and CMT97.

G Cappelli1, P Volpe, A Sanduzzi, A Sacchi, V Colizzi, F Mariani.   

Abstract

Mycobacterium tuberculosis is an intracellular pathogen that readily survives and replicates in human macrophages (MPhi). Host cells have developed different mycobactericidal mechanisms, including the production of inflammatory cytokines. The aim of this study was to compare the MPhi response, in terms of cytokine gene expression, to infection with the M. tuberculosis laboratory strain H37Rv and the clinical M. tuberculosis isolate CMT97. Both strains induce the production of interleukin-12 (IL-12) and IL-16 at comparable levels. However, the clinical isolate induces a significantly higher and more prolonged MPhi activation, as shown by reverse transcription-PCR analysis of IL-1beta, IL-6, IL-10, transforming growth factor beta, tumor necrosis factor alpha, and gamma interferon (IFN-gamma) transcripts. Interestingly, when IFN-gamma transcription is high, the number of M. tuberculosis genes expressed decreases and vice versa, whereas no mycobactericidal effect was observed in terms of bacterial growth. Expression of 11 genes was also studied in the two M. tuberculosis strains by infecting resting or activated MPhi and compared to bacterial intracellular survival. In both cases, a peculiar inverse correlation between expression of these genes and multiplication was observed. The number and type of genes expressed by the two strains differed significantly.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11705896      PMCID: PMC98810          DOI: 10.1128/IAI.69.12.7262-7270.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  36 in total

1.  Virulence of recent notorious Mycobacterium tuberculosis isolates.

Authors:  I M Orme
Journal:  Tuber Lung Dis       Date:  1999

2.  Dysregulated production of interferon-gamma, interleukin-4 and interleukin-6 in early tuberculosis patients in response to antigen 85B of Mycobacterium tuberculosis.

Authors:  E K Jo; H J Kim; J H Lim; D Min; Y Song; C H Song; T H Paik; J W Suhr; J K Park
Journal:  Scand J Immunol       Date:  2000-02       Impact factor: 3.487

3.  Transcription of two sigma 70 homologue genes, sigA and sigB, in stationary-phase Mycobacterium tuberculosis.

Authors:  Y Hu; A R Coates
Journal:  J Bacteriol       Date:  1999-01       Impact factor: 3.490

4.  Multiple epitopes from the Mycobacterium tuberculosis ESAT-6 antigen are recognized by antigen-specific human T cell lines.

Authors:  A S Mustafa; F Oftung; H A Amoudy; N M Madi; A T Abal; F Shaban; I Rosen Krands; P Andersen
Journal:  Clin Infect Dis       Date:  2000-06       Impact factor: 9.079

Review 5.  DNA topology and adaptation of Salmonella typhimurium to an intracellular environment.

Authors:  D G Marshall; F Bowe; C Hale; G Dougan; C J Dorman
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2000-05-29       Impact factor: 6.237

6.  Induction of in vitro human macrophage anti-Mycobacterium tuberculosis activity: requirement for IFN-gamma and primed lymphocytes.

Authors:  M G Bonecini-Almeida; S Chitale; I Boutsikakis; J Geng; H Doo; S He; J L Ho
Journal:  J Immunol       Date:  1998-05-01       Impact factor: 5.422

7.  T-cell recognition of Mycobacterium tuberculosis culture filtrate fractions in tuberculosis patients and their household contacts.

Authors:  A Demissie; P Ravn; J Olobo; T M Doherty; T Eguale; M Geletu; W Hailu; P Andersen; S Britton
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

8.  Mycobacterium tuberculosis CDC1551 induces a more vigorous host response in vivo and in vitro, but is not more virulent than other clinical isolates.

Authors:  C Manca; L Tsenova; C E Barry; A Bergtold; S Freeman; P A Haslett; J M Musser; V H Freedman; G Kaplan
Journal:  J Immunol       Date:  1999-06-01       Impact factor: 5.422

9.  Differential protective efficacy of DNA vaccines expressing secreted proteins of Mycobacterium tuberculosis.

Authors:  A T Kamath; C G Feng; M Macdonald; H Briscoe; W J Britton
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

10.  A novel mycolic acid cyclopropane synthetase is required for cording, persistence, and virulence of Mycobacterium tuberculosis.

Authors:  M S Glickman; J S Cox; W R Jacobs
Journal:  Mol Cell       Date:  2000-04       Impact factor: 17.970

View more
  12 in total

1.  Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in Mycobacterium tuberculosis-infected individuals.

Authors:  Clare R Sander; Ansar A Pathan; Natalie E R Beveridge; Ian Poulton; Angela Minassian; Nicola Alder; Johan Van Wijgerden; Adrian V S Hill; Fergus V Gleeson; Robert J O Davies; Geoffrey Pasvol; Helen McShane
Journal:  Am J Respir Crit Care Med       Date:  2009-01-16       Impact factor: 21.405

2.  Gene expression profiling of human macrophages at late time of infection with Mycobacterium tuberculosis.

Authors:  Elisabetta Volpe; Giulia Cappelli; Manuela Grassi; Angelo Martino; Annalucia Serafino; Vittorio Colizzi; Nunzia Sanarico; Francesca Mariani
Journal:  Immunology       Date:  2006-08       Impact factor: 7.397

3.  Down-regulation of miR-20a-5p triggers cell apoptosis to facilitate mycobacterial clearance through targeting JNK2 in human macrophages.

Authors:  Guoliang Zhang; Xi Liu; Wenfei Wang; Yi Cai; Shaoyuan Li; Qi Chen; Mingfeng Liao; Mingxia Zhang; Gucheng Zeng; Boping Zhou; Carl G Feng; Xinchun Chen
Journal:  Cell Cycle       Date:  2016-08-05       Impact factor: 4.534

Review 4.  Translational mini-review series on vaccines: Development and evaluation of improved vaccines against tuberculosis.

Authors:  C Sander; H McShane
Journal:  Clin Exp Immunol       Date:  2007-03       Impact factor: 4.330

5.  Mycobacteria lacking the RD1 region do not induce necrosis in the lungs of mice lacking interferon-gamma.

Authors:  Ana Paula Junqueira-Kipnis; Randall J Basaraba; Veronica Gruppo; Gopinath Palanisamy; Oliver C Turner; Tsungda Hsu; William R Jacobs; Scott A Fulton; Scott M Reba; W Henry Boom; Ian M Orme
Journal:  Immunology       Date:  2006-10       Impact factor: 7.397

6.  Molecular characterization of the eis promoter of Mycobacterium tuberculosis.

Authors:  Esteban A Roberts; Amanda Clark; Sarah McBeth; Richard L Friedman
Journal:  J Bacteriol       Date:  2004-08       Impact factor: 3.490

7.  Low induction of proinflammatory cytokines parallels evolutionary success of modern strains within the Mycobacterium tuberculosis Beijing genotype.

Authors:  Arjan van Laarhoven; Jornt J Mandemakers; Johanneke Kleinnijenhuis; Mimount Enaimi; Ekta Lachmandas; Leo A B Joosten; Tom H M Ottenhoff; Mihai G Netea; Dick van Soolingen; Reinout van Crevel
Journal:  Infect Immun       Date:  2013-07-29       Impact factor: 3.441

Review 8.  Innate immunity in tuberculosis: host defense vs pathogen evasion.

Authors:  Cui Hua Liu; Haiying Liu; Baoxue Ge
Journal:  Cell Mol Immunol       Date:  2017-09-11       Impact factor: 11.530

9.  Activation of the eis gene in a W-Beijing strain of Mycobacterium tuberculosis correlates with increased SigA levels and enhanced intracellular growth.

Authors:  Shiping Wu; Peter F Barnes; Buka Samten; Xiuhua Pang; Sébastien Rodrigue; Saleena Ghanny; Patricia Soteropoulos; Luc Gaudreau; Susan T Howard
Journal:  Microbiology (Reading)       Date:  2009-04       Impact factor: 2.777

10.  Different transcriptional profiles of human monocyte-derived dendritic cells infected with distinct strains of Mycobacterium tuberculosis and Mycobacterium bovis bacillus Calmette-Guérin.

Authors:  Nunzia Sanarico; Alessia Colone; Manuela Grassi; Viviana Speranza; Daniela Giovannini; Antonio Ciaramella; Vittorio Colizzi; Francesca Mariani
Journal:  Clin Dev Immunol       Date:  2011-03-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.